This website is for healthcare professionals only

If you are a healthcare professional, please select your country to visit your local website:

Change Country

If you are a HCP and would like to visit the global Hemophilia website, please confirm this by pressing the button below.

  • I am an HCP; Visit Global Website

This website contains information based on the Summary of Product Characteristics (SPC), as approved by the European Commission on Jivi (damoctog alfa pegol), Kovaltry (octocog alfa) and Kogenate FS (octocog alfa). It is intended to provide information to an international audience. In countries outside the EU, the local Product Information applies.

hidden link for autofocus
Cookie consent image
Skip to main content
  • Prescribing Information
    • Jivi
    • Kovaltry
    • Kogenate
  • Bayer Global
Alt Hemophilia Hub
  • Bayer in Hemophilia
  • Products
    • Overview
    • Jivi
      • Why Jivi?
      • The Jivi Experience
      • Bleed Resolution and Major Surgeries
      • The Jivi Molecule
      • Dosing Information
      • Administration and Monitoring
      • Study Designs
    • Kovaltry
      • Efficacy & Safety
        • Factor VIII Threshold
        • Factor VIII Activity
        • PK & Time to Threshold
        • PK Across Age
        • Safety
      • Practical Usage
        • Dosing
        • Vial Adaptor & Sizes
        • Storage
      • The Molecule
    • Kogenate FS/Bayer
  • Tools & Resources
    • Overview
    • Joint Visualiser
    • Download Resource Centre
    • myWAPPS
    • WAPPS Integrated Service
  • Latest in Hemophilia
  • Engagement Programs
  • Bayer in Hemophilia
  • Products
    • Overview
    • Jivi
      • Why Jivi?
      • The Jivi Experience
      • Bleed Resolution and Major Surgeries
      • The Jivi Molecule
      • Dosing Information
      • Administration and Monitoring
      • Study Designs
    • Kovaltry
      • Efficacy & Safety
        • Factor VIII Threshold
        • Factor VIII Activity
        • PK & Time to Threshold
        • PK Across Age
        • Safety
      • Practical Usage
        • Dosing
        • Vial Adaptor & Sizes
        • Storage
      • The Molecule
    • Kogenate FS/Bayer
  • Tools & Resources
    • Overview
    • Joint Visualiser
    • Download Resource Centre
    • myWAPPS
    • WAPPS Integrated Service
  • Latest in Hemophilia
  • Engagement Programs
  • Prescribing Information
    • Jivi
    • Kovaltry
    • Kogenate
  • Bayer Global
  • Country select
    • Gemany
    • Japan
    • United States
  • Prescribing Information
  • Bayer Global
Bayer Logo Bayer Logo Bayer Logo Bayer Logo

Kovaltry
Storage

Breadcrumb
  1. Home
  2. Products
  3. Kovaltry
  4. Practical Usage
  5. Storage

Easy storage1

Kovaltry logo
Easy storage in room temperature
Easy storage in a refrigerator

For important safety and use information, please see summary of product characteristics or country-specific prescribing information.

Recommendations

Safety Profile of Kovaltry

Kovaltry and Natural FVIII

Related Topics

Bayer in Hemophilia Tools & Resources Programs for Your Hemophilia Patients

References

  • Kovaltry Summary of Product Characteristics. Leverkusen, Germany: Bayer; 2017. Return to content
  • General Conditions of Use
  • Imprint
  • Privacy statement
  • Report a Side Effect
  • Jivi Prescribing information
  • Kovaltry Prescribing information
  • Kogenate Prescribing information
  • Contact Us
  • Sitemap
  • Cookies Settings

© 2022 Bayer AG

This website is intended to provide information to an international audience outside the USA and UK
PP-JIV-ALL-0492-2

  • PP-JIV-ALL-0302-1

Last updated: June 2022